Supreme Courts of Arkansas Reverses $1.2 Billion Judgments in Risperdal Labeling Case, Declares FDA “Warning Letters” Inadmissible Evidence Read more
Endo Health Solutions Lidoderm Settlement and Corporate Integrity Agreement, CME Obligations Read more
CareFusion Settlement Features Corporate Regulatory Officer as Whistle Blower, Implicating High Profile Physicians Read more
Bioscrip Settles with DOJ, Novartis Accused of Paying Kickbacks to Pharmacies for Exjade Patient Adherence Program Read more